Kathrine Gamborg Andreassen, Chief Executive Officer of Navamedic ASA, has
today, on 30 September 2020, exercised 125,000 share options in Navamedic ASA
with a strike price of NOK 8.88 per share, and in connection with the exercise
subscribed for 125,000 new shares in Navamedic ASA.

Following the issue of the new shares, Kathrine Gamborg Andreassen will transfer
the shares to her wholly-owned investment company, Soleglad Invest AS.

Following the issue of the new shares in Navamedic ASA, Kathrine Gamborg
Andreassen, with her related parties, will own 666,668 shares and 105,000
options in Navamedic ASA.

This information is subject of the disclosure requirements pursuant to section 4
-2 of the Norwegian Securities Trading Act.